Skip to main content

Month: January 2023

RPT Realty Announces 2022 Investment and Capital Markets Activity

NEW YORK, Jan. 10, 2023 (GLOBE NEWSWIRE) — RPT Realty (NYSE:RPT) (“RPT” or the “Company”) announced today investment and capital markets activity for the quarter and year ended December 31, 2022. “RPT continued to improve the strength of its cash flows through its investment and capital markets activities,” said Brian Harper, President and Chief Executive Officer. “We diversified the portfolio into strong and vibrant markets like Miami and Boston by capitalizing on the power of our three investment platforms. Also, we were opportunistic with our balance sheet management, completing $1.2 billion of total capital markets activity in 2022 resulting in longer duration, higher liquidity and lower floating rate exposure.” 2022 Investment Activity For the full year 2022, the Company through its three strategic investment platforms, closed...

Continue reading

Veritex Holdings, Inc. Announces Dates of Fourth Quarter and Year End 2022 Earnings Release and Conference Call

DALLAS, Jan. 10, 2023 (GLOBE NEWSWIRE) — Veritex Holdings, Inc. (Nasdaq: VBTX) (“Veritex” or “the Company”), the parent holding company for Veritex Community Bank, today announced that it plans to release its fourth quarter and year end 2022 results after the close of the market on Tuesday, January 24, 2023. The earnings release will be available on the Company’s website, https://ir.veritexbank.com/. The Company will also host an investor conference call to review the results on Wednesday, January 25, 2023 at 8:30 a.m. Central Time. Participants may access a live webcast of the conference call through the investor relations section of Veritex’s website, https://ir.veritexbank.com/ or the hosting website at https://edge.media-server.com/mmc/p/767zfwtq. Participants may also register via teleconference at:https://register.vevent.com/register/BI7ccf0c5ef7d84e35916df74d12b9e4ad....

Continue reading

First Advantage to Release Fourth Quarter and Full Year 2022 Financial Results and Hold Investor Conference Call on February 28, 2023

ATLANTA, Jan. 10, 2023 (GLOBE NEWSWIRE) — First Advantage Corporation (NASDAQ: FA), a leading global provider of HR technology solutions for screening, verifications, safety, and compliance, will issue its fourth quarter and full year 2022 financial results on Tuesday, February 28, 2023 prior to the Company’s earnings conference call, which will be held at 8:30 a.m. EST on the same day. Conference Call Details To participate in the conference call, please dial (800) 225-9448 (domestic) or (203) 518-9708 (international) approximately ten minutes before the 8:30 a.m. EST start. Please mention to the operator that you are dialing in for the First Advantage fourth quarter 2022 earnings call or provide the conference code FAQ422. The call will also be webcast live on the Company’s investor relations website at https://investors.fadv.com...

Continue reading

Integra LifeSciences Reports Select Preliminary Fourth Quarter and Full-Year 2022 Financials

Fourth Quarter 2022 Fourth quarter 2022 revenue is expected to be in a range of $397 million to $398 million, representing a decrease of approximately 2% on a reported basis and an increase of approximately 3% on an organic basis compared to 2021.Fourth quarter 2022 adjusted earnings per diluted share is expected to be above the high end of the Company’s October guidance range.Full-Year 2022 Full-year 2022 revenue is expected to be in a range of $1,557 million to $1,558 million, representing an increase of approximately 1% on a reported basis and an increase of approximately 4% on an organic basis compared to 2021.Full-year quarter 2022 adjusted earnings per diluted share is expected to be above the high end of the Company’s October guidance range.PRINCETON, N.J., Jan. 10, 2023 (GLOBE NEWSWIRE) — Integra LifeSciences...

Continue reading

Reviv3 Procare Delivers Record Second Quarter Fiscal 2023 Revenue and Earnings

Record second quarter 2023 revenues of $6.7 million, up 1,264% year-over-year. Gross profit increased to $5.0 million compared to $0.4 million for the prior year quarter. Net cash generated from operating activities of $2.2 million with a net increase in cash of over $3.6 million for the first six months of 2023. Net income before provisions for income tax of $987,944 compared to $28,201 in the prior year quarter.LOS ANGELES, Jan. 10, 2023 (GLOBE NEWSWIRE) —  Reviv3 Procare Company (OTCQB: RVIV), an emerging global e-commerce brand for hair care products and hearing protection and enhancement products, today announced its financial and operational results for second quarter of fiscal year 2023. Second Quarter Fiscal 2023 Financial Summary The company reported revenues of $6,731,999 in the second quarter of 2023 compared to...

Continue reading

Backblaze Reaffirms Guidance Ahead of Participation in Needham Growth Conference

SAN MATEO, Calif., Jan. 10, 2023 (GLOBE NEWSWIRE) — Backblaze, Inc. (Nasdaq: BLZE), the leading independent storage cloud platform, reiterated its outlook for fiscal Q4 of 2022 and full-year 2022. “In light of our participation in an upcoming investor conference, we are reaffirming the guidance we gave for Q4 and 2022 on our Q3 2022 earnings call,” said Gleb Budman, CEO and Chairperson of the Board. “This reflects continued revenue growth of over 20% Y/Y in Q4 and the strength of our recurring revenue model.” Reaffirmed Guidance (Originally issued on November 9, 2022)Fourth quarter of 2022:Revenue:      $22.5 million to $22.9 millionAdjusted EBITDA margin:    (14)% to (10)%     Full-year 2022:Revenue:      $84.7 million to $85.1 millionAdjusted EBITDA margin:     (12)% to (11)%Needham Growth Conference Backblaze...

Continue reading

Magna Announces Date for Q4 & Year End 2022 Results and 2023 Outlook Conference Call

AURORA, Ontario, Jan. 10, 2023 (GLOBE NEWSWIRE) — Magna International Inc. (TSX:MG) (NYSE:MGA) MAGNA ANNOUNCES DATE FOR Q4 & YEAR END 2022 RESULTS and 2023 OUTLOOK CONFERENCE CALL   FRIDAY – FEBRUARY 10, 2023 8:00 AM ET      DIAL IN NUMBERSToll-Free: 1-800-891-9945International: 1-416-981-9017Webcast: www.magna.comSlide presentation will be available on our website prior to the call    REBROADCAST INFORMATIONReplay available 2 hours after the call until February 17, 2023Toll-Free: 1-800-558-5253International: 1-416-626-4100Reservation No.: 22025718INVESTOR CONTACTLouis Tonelli, Vice-President, Investor Relations louis.tonelli@magna.com   905-726-7035 TELECONFERENCE CONTACTNancy Hansford, Executive Assistant, Investor Relations nancy.hansford@magna.com   905-726-7108  

Continue reading

Occidental to Announce Fourth Quarter Results Monday, February 27, 2023; Hold Conference Call Tuesday, February 28, 2023

HOUSTON, Jan. 10, 2023 (GLOBE NEWSWIRE) — Occidental (NYSE: OXY) will announce its fourth quarter 2022 financial results after close of market on Monday, February 27, 2023, and will hold a conference call to discuss results on Tuesday, February 28, 2023, at 1 p.m. Eastern/12 p.m. Central. The conference call may be accessed by calling 1-866-871-6512 (international callers dial 1-412-317-5417) or via webcast at oxy.com/investors. Participants may pre-register for the conference call at https://dpregister.com/sreg/10173524/f531c7c588.         Fourth quarter 2022 financial results will be available through the Investor Relations section of the company’s website. A recording of the webcast will be posted on the website within several hours after the call is completed. About Occidental Occidental is an international energy company...

Continue reading

Optimi Health Announces Re-Appointments to Board of Directors

VANCOUVER, British Columbia, Jan. 10, 2023 (GLOBE NEWSWIRE) — Optimi Health Corp. (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) (“Optimi” or the “Company”), is pleased to announce that Mr. Bryan Safarik, Mr. Jacob Safarik, Mr. Jon Schintler, Mr. Dane Stevens, and Mr. JJ Wilson have been re-elected to the Board of Directors following the Company’s Annual General Meeting held January 9, 2023. The Company would like to thank departing director Mr. Michael Stier for his service and wishes him well in his future endeavours. Optimi shareholders also re-appointed Smythe LLP as auditor and re-approved the Company’s Equity Incentive Plan. ABOUT OPTIMI (CSE: OPTI) (OTCQX: OPTHF) (FRA: 8BN) Optimi Health Corp. is a Canadian-based company licensed by Health Canada to produce and supply natural, EU-GMP grade psilocybin and synthetic psychedelic substances,...

Continue reading

Presentation of Preclinical Study Highlighting Anti-Cancer Activity of Rencofilstat in Combination with Proteosome Inhibitors

EDISON, N.J., Jan. 10, 2023 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on Artificial Intelligence (“AI”)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (“NASH”), hepatocellular carcinoma (“HCC”), and other chronic liver diseases, announced that its research collaborator, Carlos Perez-Stable, PhD, from the University of Miami Miller School of Medicine and Miami Veterans Affairs/Research, today presented new findings from a preclinical study on the Company’s lead drug candidate, rencofilstat, a potent inhibitor of cyclophilins, in a presentation at the 2023 State of Florida Cancer Symposium in Tampa, Florida. The presentation, entitled “A New Strategy to Increase Proteotoxic Stress in Prostate Cancer,” highlighted a preclinical...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.